Hypertensive emergencies in pregnancy

Rakesh B. Vadhera, Michelle Simon

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Hypertensive disorders of pregnancy complicate 7% to 10% of pregnancies and are among the major causes of maternal and perinatal morbidity and mortality. Recently American College of Obstetricians and Gynecologists Taskforce on Hypertension during Pregnancy modified thediagnosis and management of hypertension in pregnancy, recommending prompt diagnosis, admission, close monitoring, and treatment. They strive to decrease maternal mortality and systemic complications. Labetalol, hydralazine, or nifedipine are considered first-line treatment, and either can be used to stabilize the patient with similar outcomes. Definite treatment is delivery of the fetus and should be considered based on the etiology of the hypertensive crisis and gestational age.

Original languageEnglish (US)
Pages (from-to)797-805
Number of pages9
JournalClinical Obstetrics and Gynecology
Volume57
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • Antihypertensives
  • Hypertension
  • Hypertensive emergencies
  • Pre-eclampsia
  • Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Hypertensive emergencies in pregnancy'. Together they form a unique fingerprint.

Cite this